Indication

Cutaneous anthrax

Cutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis*. Read more about Cutaneous anthrax

147 drugs 89 manufacturers

Advertisement

Drugs that treat it

Common Cutaneous anthrax therapies.

Showing 46–54 of 147 drugs

Filter & compare in the drug finder →Opens the drug finder with Cutaneous anthrax preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cutaneous anthrax.

Cutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis*.

It typically develops in agricultural or industrial workers following direct cutaneous exposure to infected animals, contaminated animal byproducts, or aerosolized spores entering through broken skin.

The condition classically manifests as a pruritic papule that rapidly progresses to a vesicle or ring of hemorrhagic vesicles, culminating in a characteristic painless, depressed ulcer covered by a black necrotic eschar with pronounced surrounding non-pitting edema.

Driven by lethal and edema toxins released during bacterial germination, cutaneous anthrax may remain localized or, if left untreated, disseminate hematogenously, resulting in systemic illness, bacteremia, and substantial morbidity.

Personalize your experience

Follow Cutaneous anthrax and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it